Gilead Sciences
GILD
#112
Rank
S$214.18 B
Marketcap
S$172.56
Share price
-1.29%
Change (1 day)
27.65%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): S$8.85

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$8.70. In 2024 the company made an earnings per share (EPS) of S$0.48 a decrease over its 2023 EPS that were of S$5.78.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.851734.24%
2024S$0.48-91.65%
2023S$5.7823.98%
2022S$4.66-25.86%
2021S$6.294850%
2020S$0.13-97.64%
2019S$5.390.9%
2018S$5.3418.71%
2017S$4.50-64.88%
2016S$12.80-18.45%
2015S$15.7055.28%
2014S$10.11296.02%
2013S$2.5517.89%
2012S$2.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.15 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.73-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$3.04-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.24 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.20 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$11.21 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$6.96-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$19.65 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.28 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA